Search results

The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.

Scientists from Monash, ANSTo and China have developed an ultra-thin membrane that could separate harmful ions from water or capture gases.

ANSTO facilitating coordinated effort to find the nexus that leads to chronic kidney disease of unknown origin

Research undertaken by Flinders University, the University of Cincinnati (US), Guangzhou University (China) and ANSTO has evaluated a new process to encapsulate fish oil in nanoparticles

2025 ANSTO Work Experience Program will be open for applications in the new year.

Highlighting the contribution of four inspirational ANSTO leaders on International Women's Day.

Two Australian science teachers will have the chance to participate in a special two-week summer school at the Large Hadron Collider in July 2026.

The Government is safeguarding Australia’s sovereign capability to produce vital nuclear medicines by launching a $30 million project to design a new world-leading manufacturing facility to be built at Lucas Heights in Sydney.

An unassuming rock shelter in the Flinders Ranges has been revealed as the oldest known evidence of Aboriginal Australian settlement, thanks in part to advanced nuclear techniques, technology and scientists.

ANSTO has recently concluded up a successful cross-cultural nuclear science education project between Australia and Japan.

Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.